The novel proteomic signature for cardiac allograft vasculopathy.
Dong-Mei WeiSander TrensonJan M Van KeerJesus MelgarejoElla CutsforthLutgarde ThijsTianlin HeAgnieszka LatosinskaAgnieszka CiarkaThomas VanasscheLucas Van AelstStefan JanssensJohan Van CleemputHarald MischakJan A StaessenPeter VerhammeZhen-Yu ZhangPublished in: ESC heart failure (2022)
This pilot study identified and validated a urinary proteomic signature that provided a potential approach for the surveillance of CAV. These proteins might provide insights into CAV pathological processes and call for further investigation into personalized treatment targets.